ASCIDIAN Trademark

Trademark Overview

On Tuesday, May 26, 2020, a trademark application was filed for ASCIDIAN with the United States Patent and Trademark Office. The USPTO has given the ASCIDIAN trademark a serial number of 88932933. The federal status of this trademark filing is REGISTERED as of Tuesday, August 6, 2024. This trademark is owned by Pulsar Biotherapeutics, Inc. The ASCIDIAN trademark is filed in the Pharmaceutical Products category with the following description:

Biological preparations for medical use in medical and clinical gene therapy and cell therapy
ascidian

General Information

Serial Number88932933
Word MarkASCIDIAN
Filing DateTuesday, May 26, 2020
Status700 - REGISTERED
Status DateTuesday, August 6, 2024
Registration Number7469116
Registration DateTuesday, August 6, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 30, 2021

Trademark Statements

Goods and ServicesBiological preparations for medical use in medical and clinical gene therapy and cell therapy

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 12, 2020
Primary Code005
First Use Anywhere DateTuesday, May 14, 2024
First Use In Commerce DateTuesday, May 14, 2024

Trademark Owner History

Party NameASCIDIAN THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoston, MA 02135
Party NameASCIDIAN THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02135
Party NameASCIDIAN THERAPEUTICS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02142
Party NamePulsar Biotherapeutics, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Friday, May 29, 2020NEW APPLICATION ENTERED
Friday, June 12, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 12, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, August 26, 2020ASSIGNED TO EXAMINER
Thursday, August 27, 2020NON-FINAL ACTION WRITTEN
Thursday, August 27, 2020NON-FINAL ACTION E-MAILED
Thursday, August 27, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 2, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 2, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 2, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 2, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, February 2, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 2, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, February 12, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 12, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 12, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, February 12, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 23, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 23, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 24, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 25, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 30, 2021PUBLISHED FOR OPPOSITION
Tuesday, March 30, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 25, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, November 26, 2021SOU EXTENSION 1 FILED
Monday, November 29, 2021TEAS PETITION TO REVIVE RECEIVED
Monday, November 29, 2021PETITION TO REVIVE-GRANTED
Monday, November 29, 2021SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, November 30, 2021NOTICE OF REVIVAL - E-MAILED
Wednesday, January 19, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 20, 2022SOU EXTENSION 1 GRANTED
Friday, January 21, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 25, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, May 25, 2022SOU EXTENSION 2 FILED
Wednesday, May 25, 2022SOU EXTENSION 2 GRANTED
Friday, May 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 29, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 29, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 29, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, August 29, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 23, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, November 23, 2022SOU EXTENSION 3 FILED
Wednesday, November 23, 2022SOU EXTENSION 3 GRANTED
Friday, November 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 24, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, May 24, 2023SOU EXTENSION 4 FILED
Wednesday, May 24, 2023SOU EXTENSION 4 GRANTED
Friday, May 26, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 22, 2023SOU EXTENSION 5 FILED
Monday, November 27, 2023SOU EXTENSION 5 GRANTED
Tuesday, November 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 22, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, May 22, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 22, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 24, 2024STATEMENT OF USE PROCESSING COMPLETE
Wednesday, July 3, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, July 3, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 6, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, August 6, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, May 22, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, May 20, 2024USE AMENDMENT FILED
Monday, May 20, 2024TEAS STATEMENT OF USE RECEIVED

Related Keywords

ascidian therapy medical cell gene clinical preparations biological